ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

22.60
Delayed Data
As of Dec 01
 +0.32 / +1.44%
Today’s Change
14.45
Today|||52-Week Range
33.99
+41.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues58.3M59.6M63.0M83.2M
 
 
 
 
 
Cost of Goods Sold3.1M2.0M2.2M2.3M
 
 
 
 
 
Depreciation And Amortization751.0K782.0K785.0K695.0K
 
 
 
 
 
 
Operating ExpensesGross Income54.5M56.7M60.0M80.2M
 
 
 
 
 
General Expenses115.7M124.0M147.6M137.3M
 
 
 
 
 
Research And Development53.1M48.2M52.9M67.3M
 
 
 
 
 
Total Operating Expenses119.6M126.8M150.6M140.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.3M-67.3M-87.6M-57.1M
 
 
 
 
 
Other Expenses-1.7M127.0K-229.0K-12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-61.8M-65.5M-84.9M-54.6M
 
 
 
 
 
Income Taxes-376.0K-14.0K-375.0K-365.0K
 
 
 
 
 
Net Income-62.1M-65.5M-85.3M-54.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS125.0M131.6M144.0M144.3M
 
 
 
 
 
Shares To Calculate EPS Diluted125.0M131.6M144.0M144.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.50-$0.59-$0.38
 
 
 
 
 
EPS Diluted-$0.50-$0.50-$0.59-$0.38